Profil
John Hunter formerly worked at XOMA Royalty Corp., as Senior Director, Compugen Ltd., as Chief Scientific Officer, Compugen, Inc. (United States), as Vice President-Antibody R&D, Keyhole Therapeutics, Inc., as Chief Executive & Scientific Officer, and FibroGen, Inc., as Chief Scientific Officer from 2021 to 2024.
Dr. Hunter received his undergraduate degree from Hartwick College and doctorate degree from The University of California, San Francisco.
Ehemalige bekannte Positionen von John Hunter
| Unternehmen | Position | Ende |
|---|---|---|
| KYNTRA BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2024 |
| XOMA ROYALTY CORPORATION | Direktor/Vorstandsmitglied | - |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Vorstandsvorsitzender | - |
| COMPUGEN LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Ausbildung von John Hunter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Hartwick College
Hartwick College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compugen, Inc. (United States) | |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Health Technology |
















